Compare PAM & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAM | RDNT |
|---|---|---|
| Founded | 1945 | 1985 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.7B |
| IPO Year | N/A | 1986 |
| Metric | PAM | RDNT |
|---|---|---|
| Price | $89.19 | $72.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $92.75 | $83.60 |
| AVG Volume (30 Days) | 127.9K | ★ 1.1M |
| Earning Date | 11-04-2025 | 11-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | $1,926,000,000.00 | ★ $1,969,599,000.00 |
| Revenue This Year | $136,919.08 | $11.77 |
| Revenue Next Year | $36.38 | $10.76 |
| P/E Ratio | $15.76 | ★ N/A |
| Revenue Growth | N/A | ★ 11.09 |
| 52 Week Low | $54.95 | $45.00 |
| 52 Week High | $97.55 | $85.84 |
| Indicator | PAM | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 42.91 |
| Support Level | $87.94 | $71.51 |
| Resistance Level | $90.33 | $76.81 |
| Average True Range (ATR) | 2.95 | 3.72 |
| MACD | -0.57 | -0.33 |
| Stochastic Oscillator | 35.97 | 51.46 |
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.